Clinical Trial Update: Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating abuse potential of intranasal VYCAVERT tablets (hydrocodone/acetaminophen) in recreational opioid users; study completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-related Disorders

Drugs mentioned

• Vycavert (hydrocodone bitartrate/acetaminophen)

Snippet

Sponsor: Acura Pharmaceuticals Inc. | Conditions: Opioid-Related Disorders | Phase 2 | Status: COMPLETED | Results posted: 2018-11-01